Nyxoah SA
Follow $NYXH
One email when a member of Congress discloses a trade in it, with the official filing receipt linked.
Free. No account. Unsubscribe in one click.
Follow $NYXH by emailVeridion Score
BETALOW CONF · 6 of 6 factors measuredsnapshot unavailable for NYXH. Cause unavailable.
Highest qualified requires a score of at least 75 and high confidence, including full factor coverage. Upper range can hold a higher score with lower confidence.
Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.
- · Factor breakdown with raw signals
- · Day-over-day delta + driver
- · Factor coverage readout
- · Valuation · hype · market flow
- · Pro Chart event markers
- · Score history + alerts
Why is NYXH moving today?
Nyxoah SA is a health-technology company focused on the development and commercialization of solutions and services to treat sleep-disordered breathing conditions. The company's solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe Obstructive Sleep Apnea (OSA), the common sleep disordered breathing condition that is associated with increased mortality risk and comorbidities including cardiovascular diseases, depression and stroke.
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
NYXH overview
Related filings and maps
Congress activity in NYXH
No receipt-qualified Congressional disclosure is present for NYXH in the cached public ledger.
NYXH contract awards, year to date.
Public federal awards linked to this ticker.
NYXH lobbying filings, year to date.
Registered lobbying filings matched to Nyxoah SA.